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Introduction
A number of articles have been published in the ﬁelds of
neurology, nutrition, epidemiology, nephrology, and ethics,
together with interesting experimental investigations. This
year,wewantedtointegratetheworkspublishedinIntensive
CareMedicinewiththemostrelevantpapersinthesevarious
ﬁelds published in other distinguished journals.
Intensive Care Med (2012) 38:192–209
DOI 10.1007/s00134-011-2447-2 YEAR IN REVIEW 2011Nephrology
Acute kidney injury continued to be hot topic in 2011.
Early diagnosis remains an issue of increasing importance,
with the aim being to install early preventive measures in
critically ill patients. Several very promising biomarkers
turned out to have serious limitations in speciﬁc disease
states, e.g. NGAL in septic shock [1, 2]. Cystatin C is
another biomarker that is presumed to allow the early
detection of small declines in glomerular ﬁltration rate
(GFR), but may also reﬂect tubular damage if measured in
the urine. Royakkers et al. [3] investigated both urine and
serum cystatin c in a multicentre prospective observational
trial including 151 patients, and could not detect any
diagnostic value for urinary cystatin c, only a very mod-
erate performance of serum cystatin c for the prediction of
AKI (AUC 0.72), and a very poor one for predicting the
requirement for renal replacement therapy RRT (renal
replacementtherapy) (AUCB0.66).Serumcystatin C may
also be futile as a biomarker for AKI (acute kidney injury)
in the setting of renal obstruction [4].
Discrimination between transient and persistent AKI is
of clinical relevance but currently often based on urinary
indices which are not very reliable in critically ill patients.
Darmon et al. [5] used a different approach by deter-
mining Doppler resistive indices in 51 patients. They
found that a RI[0.795 predicted persistent AKI with an
OR of 1.85 (95% CI 1.2–2.85) upon applying logistic
regression analysis. Considering the large inﬂuence of
interobserver variability on this method, larger multi-
centre trials are required to prove the utility of this
method in daily clinical practice.
The question of the optimal mean arterial pressure to
optimise renal perfusion and renal function is still unre-
solved. Redfors et al. [6] approached this question in an
elegant crossover study including 12 postcardiac surgery
patients with norepinephrine-dependent vasodilatory
shock. Increasing the target mean arterial pressure (MAP)
from 60 to 75 mmHg resulted in signiﬁcantly improved
GFR (27%) and urinary output associated with increased
oxygen delivery (13%) and reduced renal oxygen con-
sumption. A further increase of MAP to 90 mmHg was
ineffective or even detrimental for these parameters. The
results indicate severely disturbed autoregulation of the
kidney in vasodilatory shock and possible beneﬁts from
targeting a higher MAP of around 75 mmHg.
Three studies investigated the epidemiology of AKI of
speciﬁc aetiologies. Hoste et al. [7] examined the inci-
dence of contrast-media induced AKI (CI-AKI) in 787
predominantly surgical (*75%) patients. As opposed to
data obtained from non-critically ill patients, the authors
found a near-threefold increased incidence, with rates of
between 16 and 23% depending on the deﬁnition used.
Contrast-induced AKI was associated with a signiﬁcantly
increased length of stay, higher requirements for renal
replacement therapy and mortality (1-year mortality 55.5
vs. 24% in patients without CI-AKI). Decreased renal
function at the time of intervention, lower mean arterial
pressure, vasoactive therapy, and administration of
diuretics were found to be major risk factors for CI-AKI.
This study, currently the largest of its kind, underlines the
importance of nephrotoxic medication in this speciﬁcally
vulnerable group of patients, and sets the stage for future
randomised trials investigating effective preventive mea-
sures against CI-AKI.
Pettila et al. [8] and Nin et al. [9] reported the epi-
demiology of AKI associated with severe H1N1
infections in different parts of the world. They found
incidence rates of AKI of between 34 and 51%, demon-
strating the high frequency of this complication in
patients suffering from H1N1 infection. The occurrence
of AKI was associated with a signiﬁcantly increased risk
of hospital mortality. Nin et al. speciﬁcally addressed the
question of early AKI versus late AKI (after ICU day 2),
and found a worse outcome for the latter, indicating that a
large proportion of early AKI occurring in the context of
H1N1 infection is presumably due to pre-renal factors like
dehydration or hypotension, which can be easily cor-
rected, resulting in rapid renal recovery. However, as
demonstrated in accompanying correspondence by Nin
et al. [10], viral particles could also be found within renal
tissue obtained from a few biopsies, which possibly
contributed to AKI. These studies provide further insight
into the pathophysiology of AKI in the setting of severe
viral infections; it is most probably a mixture of pre-renal
causes combined with endothelial damage and severe
disturbance of the coagulation system caused by exag-
gerated inﬂammatory response and ﬁnally complicated by
secondary bacterial infections. Direct renal effects of viral
inﬁltration of the kidney, however, appear to be a very
rare mechanism for AKI [11].
Sepsis is considered a well-established risk factor for
AKI, with sepsis-associated AKI showing a very modest
prognosis, substantiated by mortality rates of up to 75%
[12]. On the other hand, AKI itself is considered a sys-
temic disease associated with impaired immune function.
Mehta et al. [13] investigated the frequency and the
clinical consequences when sepsis developed as a com-
plication of AKI in 618 critically ill patients from the
multicentre PICARD study. They found that about 40% of
the patients developed sepsis at a median of 5 days after
AKI, with similar consequences for outcome as seen in
sepsis-associated AKI itself. This study demonstrates the
importance of preventing AKI as well as taking measures
against infections in patients already suffering from AKI
to avoid consecutive development of sepsis.
Another condition in which alterations in patients’
immune response may signiﬁcantly inﬂuence outcome is
liver cirrhosis. Berry et al. [14] showed that a reduction in
HLA-DR expression by monocytes to less than 40% of
193admission values was highly correlated with increased
90-day mortality. The changes in HLA-DR expression
were also associated with reduced Th1 response to anti-
genic stimulation and exaggerated secretion of the anti-
inﬂammatory cytokines IL-10 and IFN-c.
Epidemiology
Three epidemiologic studies investigated the outcomes of
postsurgical patients admitted to the ICU. Analysing the
data for 88,504 patients collected from several Austrian
ICUs over a period of 11 years, Rhodes et al. [15] found
that pre-existing morbidities such as chronic renal dis-
ease, respiratory or cardiac failure, cirrhosis, alcoholism,
acute kidney injury or nonmetastatic cancer signiﬁcantly
impaired outcome. Independent from those risks, reason
for admission, urgency of operation, age and SAPS II
score turned out to be major factors associated with
hospital mortality. An interesting observation was the fact
that survival had improved over the investigated period of
11 years.
Another important risk factor for increased morbidity
and mortality appears to be postoperative red blood cell
transfusion, as shown by Mohnle et al. [16], who analysed
a cohort of 945 patients with a low-to-moderate risk
proﬁle after coronary artery bypass grafting among 5,436
patients enrolled in an international multicentre trial.
Patients receiving red blood cell transfusions had a higher
likelihood of experiencing cardiac events or harvest site
infections, and suffered from impaired composite mor-
bidity outcome which included hospital mortality, renal
failure, pneumonia and mediastinitis.
An increased body mass index may be protective in
surgical intensive care unit patients. Hutagalung et al. [17,
18] analysed ICU and hospital mortality in 9,935 patients,
and found that both overweight (BMI 25–29.9 kg/m
2) and
obese (BMI 30–39.9 kg/m
2) patients showed a signiﬁ-
cantly lower 60-day hospital mortality than very obese
and even normal weight patients. Interestingly, the
improved survival prevailed despite a higher incidence of
AKI in these speciﬁc weight groups, as already shown in
another recent study [18].
The association of older age and outcome with pro-
longed ICU stay was investigated in a cohort of 11,395
cardiac surgery patients by Ettema et al. [19]. The authors
were able to demonstrate that all three major currently
applied prediction models for outcome—the Parsonnet
model, the Huijskes model and the EuroSCORE—showed
poor calibration with age [70 and decreasing discrimi-
nation, which was worst for age [80 (AUCs were 0.68,
0.69 and 0.64, respectively). Obviously, outcome and
recovery in older patients is rather more dependent on
their general condition than on the conventional param-
eters used for scoring systems.
Predictors of mortality
Simple, widely available lab tests could represent useful
markers and predictors of outcome in ICU patients, espe-
cially when a strong rationale supports their potential
prognostic value. For instance, eosinophil count is tightly
and readily regulated by cytokines and is related to the
stimulation of the adrenal axis. Likewise, the presence of
eosinopenia has already been reported as a marker of
infection. In a large prospective study, Abidi et al. [20]
evaluated the prognostic value of serial eosinophil count
measured daily from ICU admission until the seventh day
of stay in 200 patients. The absolute eosinophil count was
lowerovertheentireICUstayinnonsurvivors.Eosinopenia
(\40 cells/mm
3) was found to be an independent predictor
ofICUmortality,withanareaundertheROCcurveof0.82.
These ﬁndings highlight the usefulness of the inexpensive
and probably underused leukocyte formula in the ICU.
Similarly, the presence of hypoxic hepatitis—deﬁned
as the presence of a transient increase in serum amino-
transferase activity of over 20 times the upper limit of the
normal range in the absence of putative causes of liver
necrosis (virus, drugs)—in patients with cardiocirculatory
or respiratory failure was carefully scrutinised in a large
cohort of 1,066 patients admitted to a medical ICU [21].
The mortality of the 118 patients who fulﬁlled the criteria
of hypoxic hepatitis was indeed increased, especially in
the subgroup of patients who required vasopressor ther-
apy. After adjustment, the presence of hypoxic hepatitis
was found to be a strong independent risk factor for
mortality in patients receiving vasopressor therapy.
Another common ﬁnding is corticosteroid insufﬁciency
related to critical illness, a condition associated with
increased mortality. The diagnosis of this condition is
challenging,astheusefulnessoftheACTHtestaswellasthe
type of cortisol assay that should be used are still debated.
Molenaar et al. [22] compared the values of total and free
cortisol after an ACTH test. They found in a set of 112
patients(49withsepsis)thatthediagnosisofadrenalfailure
was not affected by the type of test used, as free and total
cortisol measurements were closely related. These ﬁndings
could have important implications for daily practice.
Predictors of outcome of sepsis
and physiopathological insights
The search for biomarkers of sepsis outcome is an intense
ﬁeld of clinical research. Several new potential markers
were assessed and validated by different teams who
published their reports in the journal in 2011. An early
rise in circulating endothelial protein C was found to be
associated with a high mortality [23]. This ﬁnding con-
ﬁrms the activation of coagulation at the initial stage of
sepsis, and suggests a pathogenetic role for endothelial
protein C in the pathway.
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troponin T detected by a high-sensitivity assay was found
to be elevated in all patients with severe sepsis, and this
level was correlated with other indices of poor outcome of
sepsis, even though it was not found to be an independent
predictor of survival. These ﬁndings further support the
presence of myocardial injury in sepsis, in proportion to
the severity of the sepsis, consistent with other data.
Likewise, the risk of acquisition of a second infection
in patients with sepsis was found to be increased when the
dendritic cell count was persistently low [25]. A selective
depletion of circulating plasmacytoid and myeloid den-
dritic cells was demonstrated by these authors and by
others early after the onset of sepsis. The study suggests
that the persistence of low levels increases susceptibility
to the development of a second infection, and opens up a
large ﬁeld for further research.
High-mobility group box 1 is a histone that plays a
role in the coordination of inﬂammatory pathways. Bar-
nay-Verdier et al. [26] demonstrated the presence of
antibodies directed against high-mobility group box 1 in
plasma samples from patients with sepsis. The presence
of these antibodies could play a protective role, since the
mortality was found to be lower in patients with the
highest levels. Moreover, the emergence of these anti-
bodies during the course of sepsis was detected more
often in survivors than in nonsurvivors.
The pathogenesis of encephalopathy associated with
sepsis could include mitochondrial dysfunction. There-
fore, mutationsand polymorphismsof mitochondrialDNA
might affect the cerebral response to sepsis. In a well-
deﬁned cohort of Chinese patients with sepsis, Yang et al.
[27] found that a haplogroup of mitochondrial DNA was a
strong predictive factor for the development of septic
encephalopathy. If conﬁrmed in other populations, such
ﬁndings pave the way for genomic research in the ICU.
In another exciting line of clinical research, the met-
abolic alterations of subcutaneous fat tissue were
characterised by microdialysis [28]. These researchers
found that tissue glycerol and glucose levels were higher
during septic shock than during severe sepsis. In contrast,
lactate, pyruvate and lactate-to-pyruvate ratios were
similar in both conditions. These important ﬁndings are
likely to change our understanding of the role of fat tissue
in the metabolic response to sepsis.
Nutrition and therapeutics
In 2011, several important ﬁndings in the ﬁelds of
metabolism and therapy were reported in the journal.
These were new physiopathological insights based on
commonly recorded data, or more sophisticated approa-
ches using cutting-edge technologies. New therapeutic
advances were presented as well.
Blood glucose concentration and glucose metabolism
continuous to be a major topic of interest and is still
controversial. During the last decade, neither the most
cited study in Intensive Care Medicine [29] nor the largest
interventional study published in Intensive Care Medicine
[30] has been able to settle the issue of tight glucose
control. During 2011, Mackenzie et al. [31] contributed
with a systematic analysis of a local database containing
blood glucose concentrations and outcomes using a metric
methodology. In principle, three different measures that
inﬂuenced outcomes in terms of mortality were identiﬁed
out of the blood glucose concentrations; hyperglycaemia,
hypoglycaemia, and glucose variability. Needless to say,
the study did not include the possibility of differentiating
the relative predictive values of the three measures, but as
pointed out by Krinsley [32] in an accompanying edito-
rial, future studies of blood glucose control cannot avoid
including all three measures.
Meyfroidt et al. [33] from the working group who pre-
sented the initial report on tight glucose control, reported
the advantage of an automatic predeﬁned blood glucose
threshold.Theincidenceofhypoglycaemiawasreducedby
1/3, but the variability of blood glucose was not affected.
The difﬁculties involved in feeding critically ill
patients by the enteral route are well recognised. Often it
is gastric emptying that is the problem. Nguyen et al. [34]
have investigated the absorption of fat and carbohydrates
in the small intestine in relation to motility following
surgical repair of abdominal aortic aneurysms. Motility
was impaired as compared to controls. This resulted in
reduced absorbtion of both fat and carbohydrate. Over
time, it was demonstrated that the reduced fat absorbtion
was more prolonged after the surgical procedure. This
technique opens up interesting possibilities and seems
suited for use in evaluations of other groups of critically
ill patients, and perhaps to guide the composition of
enteral formulations as suggested by the authors.
The optimal nutrition of critical ill patients is a really
hot topic, in particular after the EPaNIC study favouring
delayed parenteral nutrition [35]. The TICACOS study by
Singer et al. [36] is a pilot study in mechanically venti-
lated patients (n = 112) employing a bundle comprising
supervised nutrition intervention including indirect calo-
rimetry, as compared to a body weight guided protocol.
The indirect calorimetry group received a higher intake of
calories and protein, demonstrating the feasibility of
indirect calorimetry. The fact that higher intake was also
associated with a longer ICU stay is in total accord with
the abovementioned EPaNIC study. As pointed out in an
accompanying editorial, the use of indirect calorimetry
should be recommended to individualise nutrition,
extending follow-up beyond the doors of the hospital [37].
Another important part of nutrition is selenium supple-
mentation, as most countries in Europe have a low natural
abundance of selenium, and inﬂammatory states lower the
plasma concentration further. Recent studies have
195demonstrated a survival advantage of selenium supple-
mentation [38]. Manzanares et al. [39] report a study with
highseleniumsupplementation:2.0 mgasabolusfollowed
by 1.6 mg/24 h for 10 days. The high dose of selenium
resultedinstimulationofglutathioneperoxidaseandalower
incidence of hospital-acquired pneumonias. The clinical
advantageintermsofmorbidityinthiscomparativelysmall
study(n = 35)indicatesthatpromptrestorationofselenium
status early in the course of critical illness is important.
The muscle protein depletion seen during critical ill-
ness is present in all age groups. Tuvdendorj et al. [40]
report quantitative measurements of skeletal muscle pro-
tein turnover, including separate measurements of the
synthesis rate and the degradation rate in patients with
extensive burn injuries. Muscle protein degradation was
increased regardless of age, but the synthesis rate was
higher in children, resulting in a signiﬁcantly better pro-
tein net balance in children. This ﬁnding is in line with
earlier clinical reports of separate studies in children and
adults of protein turnover in critical illness, but this
ﬁnding of Tuvdendorj et al. is original, as it has never
before been demonstrated in a homogeneous patient
population dichotomised for age. Still, the generalisability
beyond burn injury remains to be demonstrated.
Modulating oxidative stress by increasing endogenous
antioxidant defence mechanisms has already been inten-
sively investigated. A new set of data was presented in the
journal this year [41]. The administration of pharmaco-
logical doses of selenium for 14 days in 75 patients with
systemic inﬂammation or sepsis allowed an increase in
glutathioneperoxidaseactivityascomparedto75untreated
patients. However, no change was found in mortality, even
in subgroups of patients stratiﬁed by severity of disease or
organ failures. The modalities and indications for antioxi-
dant strategies should deﬁnitely be carefully scrutinised in
the future. Paraquat intoxication is a prototypical example
of oxidative stress associated with high mortality. In such
cases, therapeutic options and antidotes are scarce. A
new treatment algorithm (high-dose cyclophospha-
mide ? high-dose methylprednisolone) has been assessed
and compared to the previous treatment (cyclophospha-
mide ? dexamethasone) in a very large cohort of 111
patients with paraquat poisoning [42]. Mortality was
decreasedfrom92to66%inpatientsrandomisedtothenew
algorithm.These importantresults obviouslybring amajor
contribution to the ﬁeld of toxicology.
Neurology
Searching for markers of cerebral vasospasm
The occurrence of symptomatic cerebral vasospasm (SCV)
after aneurysmal subarachnoid haemorrhage (aSAH) is a
frequent clinical condition that is unfortunately associated
withworsenedmorbidityandmortality[43,44].Theability
to predict patients at high risk for vasospasm would help in
targeting early therapeutical efforts. So far, this has
remained an unsatisﬁed plea [45]. In the ICU, clinical
assessment by bedside evaluation is of limited usefulness
duetosedationorclinicalseverity.TranscranialDopplerisa
useful screening tool for middle cerebral artery vasospasm,
with less utility in evaluating other intracranial vessels, and
computed tomographic perfusion may help predict vaso-
spasm when used early during the clinical course [46]. Due
tothedifﬁcultiesinvolvedinidentifyingSCV,severalearly
markers that could be used to provide therapies focused on
earlybraindamagesignshavebeensearchfor,withtheaims
being to prevent but also reduce the intensity of later
developing neurological complications [47]. Turck [48]
used an awkward panel including four brain injury-related
proteins, one cardiac marker and a clinical score, and
demonstrated that this is a valuable albeit complex tool for
identifying aSAH patients at risk of poor outcome.
Recently, pentraxin 3 (PTX3), a protein induced by
proinﬂammatory signals produced by neutrophils, macro-
phages, myeloid dendritic and endothelial cells, has
emerged as a key player in local inﬂammatory and
ischaemic events, and it has been proposed as a valuable
prognostic and diagnostic tool in many conditions, sub-
stantiating the evidence that PTX3 has useful features for a
potential biomarker. In this context, Zanier [49] investi-
gatedtheconcentrationsofPTX3anditsrelationwithSCV
in the plasma and cerebrospinal ﬂuid (CSF) of 38 aSAH
patients. PTX3 was elevated in all SAH patients in both
plasma and CSF. Early, acute peak CSF PTX3 was sig-
niﬁcantlyhigherinpatientswholaterdevelopedvasospasm
[median 13.6 (range 2.3–51.9) ng/ml] compared to those
whodidnot[3.2(0.1–50.5)ng/ml,p = 0.03].Thetemporal
pattern of CSF PTX3 in patients with vasospasm was tri-
phasic, with a peak during the ﬁrst 48 h after SAH, a
subsequent decrease in the following 48–96 h, and a sec-
ondary signiﬁcant increase with the occurrence of
vasospasm. The measurement of CSF PTX3 can improve
early diagnosis of this complication, and will be evaluated
asapotentialearlybiomarkerinfurtherresearches.Evenif
we are improving in the identiﬁcation of potential bio-
markers to use as an early warning for CVS, this search is
not yet concluded, and in the future we will probably
ameliorate our comprehension in this exciting ﬁeld.
Barbiturate therapy for refractory ICP
High intracranial pressure (HICP) frequently complicates
severe traumatic brain injury, aSAH and other neurolog-
ical disorders. Raised intracranial pressure has been
consistently associated with poor neurological outcome.
Treggiari [50], in a systematic review of trauma patients,
evaluated the management of raised ICP and related
neurological outcomes. ICP refractory to therapy and the
response to treatment are very good predictors of
196neurological outcome compared to absolute ICP values.
Relative to normal ICP, raised ICP was associated with a
3.5- to 6.9-fold increase in mortality. Raised but reducible
ICP was associated with a 3- to 4-fold increase in the
probability of death or poor neurological outcome.
Refractory ICP pattern was associated with a dramatic
increase in the relative risk of death (odds ratio [110).
The same applies to aSAH patients [51].
Our efforts at controlling HICP encompass the use of
ﬁrst-line therapies (CSF withdrawal, sedation, osmotics,
hyperventilation, CPP optimisation). If all of these fail and
the patient is salvable, we are obliged to use ‘‘second-tier’’
therapies, including barbiturates, hypothermia and de-
compressive craniectomy. High doses of barbiturates are
still recommended to control HICP refractory after the
failure of maximal standard medical and surgical therapy
[52]. Along with many other severe side effects, the most
important being haemodynamic instability and pulmonary
complications, dyskalaemia has been described as a severe
adverseeffectincasereports[53,54].Thiopentoneinhibits
voltage-dependent potassium currents and inhibits phos-
phofructokinase, causing intracellular sequestration of
potassium during its administration and an extracellular
release when it is stopped. For this reason, the discontinu-
ation of the drug must not be abrupt; it has to be slowly
tapered. However, the real incidence and characteristics of
dyskalaemia during and after barbiturate coma have not
been well described. Ng et al. [55] performed a retrospec-
tive review of all 47 patients who received barbiturate
therapyforrefractoryHICPduringan18-monthperiodina
neurosurgical ICU. 89.4% of the barbiturate patients’
cohort developed hypokalaemia after the induction of
barbiturate therapy. The median time to onset of hypokal-
aemia was 11 h and the time to nadir of serum potassium
levelswas25 h.Moreimportantly,34%patientsdeveloped
hyperkalaemia on weaning off barbiturate therapy. All
patients who developed hyperkalaemia had previously
been hypokalaemic. The mean potassium replaced during
hypokalaemia was higher in patients who developed hy-
perkalaemia compared to those who did not. Therefore,
hypokalaemiaandhyperkalaemiaarefrequentlyassociated
with induction and cessation of barbiturate coma. Serum
potassium levels must be monitored vigilantly. Patients
who develop hypokalaemia and receive large potassium
replacement may be at greater risk of hyperkalaemia on
cessation. Hyperkalaemia at cessation has been described
as cause of cardiac arrest in this population.
Cerebral monitoring
Not all monitors give you the same numbers! The physi-
ological idea behind cerebral oxygen monitoringis that the
PbrO2 value accurately represents the balance between
oxygen delivery and oxygen consumption in brain cells,
and that changes in PbrO2 will therefore reﬂect
pathophysiological alterations. These changes could then
be used to guide treatments to prevent or mitigate hypoxic
injury [56]. PbrO2 has been frequently monitored using a
Licox system (LX, Integra Neuroscience, Biot, France),
the only available device until a couple of years ago.
Recently, a different manufacturer (Raumedic, Mu ¨nch-
berg, Germany) introduced a new probe, the Neurovent-
PTO (NV). Dengler [57] compared the performance of the
two systems in 11 comatose traumatic brain injury (TBI)
or aSAH patients during dynamic changes in inspirational
oxygen fraction and mean arterial pressure. PbrO2 was
recorded continuously in patients using the two probes
which were placed side-by-side in the same cerebrovas-
cular region. Once a steady baseline value was reached,
FiO2 was increased by 20% for 10 min. Once the baseline
was again achieved, MAP was increased by 20 mmHg for
10 min. The PbrO2 values of both probes differed signif-
icantly at all times. The LX probe reacted signiﬁcantly
faster to changes in FiO2 and MAP. Limits of agreement
ranged between -32.1 and 20.0 mmHg. Mean LX values
were 6.1 mmHg lower than NV values. Even if the
examined patient cohort was rather small, the data suggest
that LX and NV probes measure different PbrO2 values in
routine monitoring as well as during phases of dynamic
changes in FiO2 and MAP. These data therefore do not
support the view that both probes can be used inter-
changeably. The practical advice for the clinician is to be
aware of the performance of the system they are using and
to adapt treatment thresholds accordingly.
Lescot and co-workers [58] tested intracranial pressure
monitors in a study on neurosurgical intensive care
patients. They used the Pressio and the Codman devices
and compared the results with direct intraventricular
measurement. They found that both pressure monitors
approximated intraventricular cerebrospinal ﬂuid pressure
with an accuracy of ±7 mmHg, a result that may be
acceptable under many clinical conditions.
In another study, the brain temperature was measured
using two different magnetic resonance techniques [59].
Healthyvolunteerswereexposedtointranasalcooling,and
brain temperature changes were measured and mapped
using MR spectroscopic imaging and phase-mapping
techniques. The decrease in brain temperature assessed by
MR was -1.7C by spectroscopic imaging and -1.8Cb y
phasemappingattheendof1 hofnasalcooling.Therectal
temperature fell by 0.5C. Thus, the simple nasal cooling
technique had a substantial effect on brain temperature.
Ethical and legal issues
End-of-life care in speciﬁc countries
During 2011 in Intensive Care Medicine, there were three
articles that focused on end-of-life care in speciﬁc
197countries. First, Solarino and colleagues conducted a
national survey of Italian physicians following the a high
proﬁle death of a 36-year-old woman who had been in a
vegetative state for 17 years [60]. The Italian Supreme
Court granted the woman’s father his wish to discontinue
nutrition and hydration. The authors of this paper emailed
a questionnaire to 70,000 physicians working for the
Italian Public Health System and University Medical
Hospitals. 22,219 doctors responded, representing a
response rate of 32%. Approximately three-quarters had
experience in treating patients in a persistent vegetative
state. Approximately 60% of them considered tube feed-
ing to be a medical therapy, and 66% believed that
withdrawing artiﬁcial nutrition and hydration could be
appropriate if based on the patient’s wishes. There was
broad consensus among Italian physicians that a clear
legislative position regarding the withdrawal of artiﬁcial
nutrition and hydration is needed.
Second, Weng and colleagues [61] conducted an
anonymous survey of the attitude of Chinese intensivists
toward end-of-life care in the ICU. Although no list of
Chinese intensivists exists, they used an innovative
snowball method to identify 534 potential participants
from 21 regions in China. The response rate was 59%.
The authors found that approximately 60% of physicians
reported admitting patients with very poor prognosis to
the ICU, and only 19% reported giving complete infor-
mation to the patients and their families. The use of do-
not-resuscitate orders or the limitation of life-sustaining
therapy in terminally ill patients was uncommon. Inter-
estingly, the authors compared their results to studies
using the same survey in Hong Kong and in Europe. In-
tensivists in China were equally likely to admit patients
with poor prognosis to the ICU as those in Hong Kong
and Europe, but were less likely to report withholding or
withdrawing life support.
Finally, Kubler and colleagues [62] reported the
results of a survey of intensivists attending a national
intensive care congress in Poland. Of the 400 question-
naires distributed, 54% were returned. Almost all
respondents (93%) reported that they had withheld life
support, and 75% of the respondents reported that they
had withdrawn life support. Older physicians and those
who reported no religious afﬁliation were more likely to
report withholding life support. Respondents from large
hospitals ([400 beds) were also more likely to report
foregoing life support in ICU patients. These results were
similar to a study conducted in Western Europe using the
same questionnaire.
Communication and collaboration in end-of-life care
A qualitative study by Lind and colleagues [63] studied
family members’ experiences of end-of-life decision-
making in Norwegian ICUs, in order to ascertain the
degree to which the family felt informed and included in
decision-making. The authors used a grounded theory
method of qualitative analysis with interviews of 27
bereaved family members. This study found that family
members wanted a more active role in decision-making,
in order to be able to communicate the values and pref-
erences of the patient. The authors also found that
clinicians often used a ‘‘wait and see’’ strategy to address
decision-making early in the ICU stay, which many
family members experienced as unnecessarily delaying
the family members’ ability to come to terms with the
severity of the patient’s illness and to participate in
decision-making. Family members also discussed the
importance of communication with ICU nurses. The
authors suggest that ICU clinicians need more training in
the knowledge and skills of effective communication with
families of critically ill patients.
Jensen and colleagues [64] conducted a survey of
nurses and physicians in the ICU as well as physicians in
primary care to examine communication and collabora-
tion between ICU and primary care clinicians regarding
decisions to forego life support in the ICU. The study was
conducted in seven hospitals in Southern Denmark. Par-
ticipants included 495 ICU nurses, 135 ICU physicians,
and 146 primary physicians, with an overall response rate
of 84%. Among primary care physicians, approximately
60% found their experience of collaboration to be satis-
factory, compared to only 36% of ICU physicians and
27% of ICU nurses. ICU physicians and nurses were more
likely than primary care physicians to perceive that
decisions regarding withdrawal of life support were
unnecessarily postponed due to communication between
ICU and primary care clinicians. The authors suggest that
multidisciplinary patient conferences, nurse involvement
in the decision-making process, and guidelines for fore-
going life support might improve communication and
collaboration.
End-of-life care in paediatric ICUs
Cremer and colleagues [65] conducted a multicentre
prospective observational study to assess the prevalence
of questioning about the appropriateness of initiating or
maintaining life support in 15 French-speaking paediatric
ICUs, and to evaluate decision-making processes. Among
the 5,602 children admitted, 410 died (7%) and 175 of
those (43% of the deaths) died after foregoing life sup-
port. The utility of life support was questioned in 308
children (6%) with a prevalence of 13 per 100 patient-
days. More than 30% of the children survived despite the
appropriateness of life support being questioned, and 23%
survived despite a decision to forego life support. The
median clinician time spent on making and presenting
decisions about the utility of life support was considerable
at 11 h per child. On any given day in each paediatric
198ICU, there was more than one child for whom a decision
to forego life support was being considered, representing
a signiﬁcant amount of paediatric ICU clinicians’ time,
and suggesting that this is an important part of paediatric
intensive care.
Devictor and colleagues [66] conducted a multicenter
prospective study, the Eurydice II study, in 45 paediatric
ICUs in Europe. They identiﬁed decisions to forego life
support in 166 children, representing 41% of the paedi-
atric deaths. They found some regional variability, with
more patients dying after CPR in Eastern and Central
Europe than in Northern and Western Europe. The vast
majority of decisions to forego life support were dis-
cussed by clinicians and families during a formal family
meeting, after which the medical staff generally made the
ﬁnal decision. The decision was almost always docu-
mented in the medical record. The majority of parents
were informed of the ﬁnal decision and were at the bed-
side during their child’s death. Decisions were made to
forego life-sustaining treatment in 41% of children who
died, which was higher than the 33% seen in Eurydice I
conducted in 2002, 6–7 years earlier. Eurydice II found
that a higher percentage of parents were now informed
about the meeting and its conclusion as compared with
the earlier Eurydice I. This study shows a trend towards
the standardisation of paediatric end-of-life practices
across European countries in the past decade, with
increased communication with the parents of critically ill
children.
Resource allocation and identiﬁcation of organ donors
Kohn and colleagues [67] sent questionnaires to a national
sample of US ICU clinicians, soliciting their preferences
for allocating their last bed to a gravely ill patient with
little chance of surviving versus a deceased or dying
patient for whom aggressive management could help
others through organ donation. The authors received
completed surveys from 684 of 2,206 physicians (31%)
and 438 of 988 nurses (44%). They found that physicians
were more likely than nurses to adhere to the ‘‘rule of
rescue’’ by allocating the last bed to the gravely ill patient
(46 vs. 33%). The magnitude of the social beneﬁt to be
obtained through organ donor management (5 or 30 life-
years added for transplant recipients) had small and
inconsistent effects on clinicians’ willingness to prioritise
the donor. The most common reason for allocating the last
bed to an identiﬁable patient was that clinicians perceived
strong obligations to identiﬁable living patients.
The authors argue that this allegiance to the rule of
rescue will be a major challenge for efforts to develop
ethical and standardised ICU triage practices.
In order to identify a potential organ donor as early as
possible and maximise the donor conversion rate, it is
important to study this conversion rate. However, the
donor conversion rate is calculated with different
assessment tools, making it difﬁcult to compare across
studies and centres. de Groot and colleagues [68] con-
ducted a study to determine which assessment tool can be
used for a realistic estimation of a potential organ donor
pool, and how they compare to each other with regard to
the donor conversion rate. They conducted a retrospective
chart review of patients diagnosed with a subarachnoid
haemorrhage, traumatic brain injury, or intracerebral
haemorrhage, and applied three different assessment
tools. In their cohort of patients, 179 out of 564 (32%)
died. After applying three different assessment tools, the
number of patients found to be brain dead, before
exclusion due to medical reasons or age, ranged from 76
to 107 patients. The authors identiﬁed one tool that was
the most practical for identifying patients with a realistic
chance of becoming brain dead and therefore identifying
the patients most likely to become a potential organ
donor.
Experimentals
Acute lung injury and mechanical ventilation
Most previous studies have focused on the propagation of
epithelial and endothelial injury in ALI/ARDS; the ability
of bacteria to colonise host defense mechanisms are not
well studied in this pathophysiologic process. Piccin and
colleagues [69] examined the hypothesis that mechanical
ventilation directly affects respiratory defense mecha-
nisms (the mucociliary system). The authors used
different modes of mechanical ventilation in rabbits, and
demonstrated that mechanical ventilation using high
volume and high pressure led to detrimental changes in
the large proximal airway mucociliary system compared
with lower tidal volume ventilation. Although a signiﬁ-
cant decrease in tracheal mucus secretion was noted
across all ventilated groups, only animals ventilated with
high pressures showed a signiﬁcant reduction in ciliary
beating frequency. The authors speculated that the mu-
cociliary alterations occurred as a result of tissue
hypoperfusion caused by mechanical ventilation with
high pressures and high airway ﬂows. An editorial [70]
pointed out that the relevance of the observation is yet to
be investigated in patients under mechanical ventilation.
It is nevertheless important to understand the effects
of changes in mucociliary clearance in the context of
ventilator-induced lung injury that may alter host sus-
ceptibility to infections or prolonged intubations due to
secretion retention.
Mechanicalventilation with high tidalvolume increased
the generation of reactive oxygen stress (ROS), cytokine
responses, and the activation of mitogen-activated protein
kinase(MAPK)andnuclearfactor(NF)-jBassociatedwith
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administration of apocynin, a strong oxidative inhibitor
known to block nicotinamide adenine dinucleotide phos-
phate (NADPH) oxidase in neutrophils, macrophages, and
endothelium [72–74], depressed oxidative stress, attenu-
ated inﬂammatory responses, and reduced ventilator-
induced lung injury (VILI) [71].
Resolution of the alveolar epithelial/capillary mem-
brane damage that occurs during acute lung injury (ALI)
requires a coordinated and effective tissue reconstruction
program to re-establish a functional barrier [75]. Regen-
eration of alveolar epithelial cells and matrix turnover are
controlled by regulatory pathways, while dysregulation of
these pathways may result in ampliﬁcation of the initial
injury and disorderly repair, with sustained inﬂammation
and development of pulmonary ﬁbrosis [76, 77]. Since
WNT/b-catenin signaling has been reported to be
involved in epithelial cell injury [78], Villar et al. [79]
demonstrated that this pathway is modulated early during
ventilator-induced lung injury. This modulation may
represent a promising therapeutic target for attenuating or
preventing the pathological consequences of acute lung
injury.
The mechanisms of ventilator-induced diaphragmatic
damage (VIDD) are not fully elucidated [80]. Previous
studies have shown that high tidal volume ventilation
leads to the activation of serine/threonine kinase/protein
kinase B (Akt) and c-Jun NH2-terminal kinase (JNKs)
[81]. Activation of the phosphoinositide 3-OH kinase
(PI3-K)/Akt pathway also results in the phosphorylation
of the class O of forkhead box transcription factor (Foxo)
proteins [82]. Li et al. demonstrated that a high tidal
volume ventilation-induced diaphragmatic damage model
was associated with the activation of JNK and Foxo4, and
this process was dependent on the Akt and JNK pathways.
These data help us to understand the effects of mechanical
forces on the diaphragmatic injury, as well as suggest
whether inhibiting the Akt and JNK pathways offers
possible treatment options [83].
Previous studies have shown that high-dose cortico-
steroids or neuromuscular blocking agents (NMBA) [84]
may affect diaphragm function [85]. Maes et al. [86]
hypothesised that the combination of rocuronium
(NMBA) and corticosteroids would result in a further
deterioration of diaphragm function in a model of venti-
lator-induced diaphragm dysfunction (VIDD). They
observed that the negative effect of rocuronium infusion
with controlled mechanical ventilation was absent with
the administration of a high dose of corticosteroid due to
inhibition of the calpain and caspase-3 system.
It has been suggested that the airway pressure used in
the mechanical ventilation of patients with ALI/ARDS
should be in-between the low and upper inﬂection points
of the pressure–volume (P–V) curve. During constant
inspiratory ﬂow, analysis of the airway pressure–time
proﬁle (P–t) can replace the static P–V curve [87]. From
the mathematical point of view, the airway pressure can
be described as a function of inspiratory time by the
following equation: airway pressure = at
b ? c, where the
coefﬁcient b, called the stress index, describes the shape
of the P–t curve during a tidal breath. If b\1, it means
that the compliance increases, suggesting tidal recruit-
ment; if b = 1, it suggests that the compliance does not
change, while if b[1, it indicates compliance decreases,
suggesting tidal overinﬂation [88]. Formenti et al. [89]
tested the predictive ability of the stress index compared
with quantitative lung CT scan in paralysed, mechanically
ventilated pigs. The tests were conducted at PEEP values
of 1 and 10 cm H2O in the absence and presence of
pleural effusion by ﬂuid instillation in pleural space. The
investigators demonstrated a dissociation between the
stress index, which suggested lung overinﬂation, and the
CT scan, which showed lung recruitment. This observa-
tion suggests that the ability of the stress index to predict
lung recruitment and overdistension was signiﬁcantly
reduced in the pathophysiological conditions. However,
the authors did not measure the transpulmonary pressure
in their study. An editorial [90] suggests that computation
of the stress index as usually obtained from the airway
pressure curve should be replaced by analysis of the
transpulmonary pressure curve proﬁle. In the heteroge-
neous airspace environment of ALI/ARDS, a reliable tool
at the bedside to set desirable PEEP and VT is critical
[91]. Traditional methods of monitoring lung mechanics
using the pressure–volume curve, static compliance and
the stress index have shown drawbacks, especially when
the compliance of the chest wall is altered. Computed
tomography (CT) scan is a powerful tool for mapping the
distribution of the gas volume, but it is yet to be a part of
bedside technology. The forced oscillation technique
(FOT) may offer several potential advantages over tra-
ditional methods because it applies very small volume
displacement, it minimises artifacts resulting from non-
linearity of the respiratory system, and it does not require
deep sedation and muscle paralysis. Using FOT in a
surfactant depletion model of ALI, Dellaca and col-
leagues [92] performed incremental and decremental
PEEP trials, and measured both conventional and FOT-
derived respiratory system compliance at each step of
PEEP changes. CT scan analysis was performed as a gold
standard for monitoring lung compartments at end expi-
ration. FOT was able to detect the minimal PEEP value
needed to keep the lung open, and this was in good
agreement with CT scan analysis with respect to sensi-
tivity and speciﬁcity, suggesting that FOT may have
potential value in deﬁning adequate levels of PEEP to
prevent/reduce the occurrence of de-recruitment. How-
ever, the validation of FOT to detect the extent of
recruitment/de-recruitment and hyperinﬂation remains to
be determined in more complicated clinical situations
[93]. Variable ventilation is a new mode delivering vol-
ume-controlled ventilation with variation of the tidal
200volume around an average value. Pillow et al. [94] found
that variable ventilation increased dynamic compliance
but not static compliance or oxygenation in preterm
lambs. They also found decreased PaCO2 and concluded
that variable ventilation was more efﬁcient than conven-
tional ventilation. The authors speculated that the lack of
improvement in oxygenation between the groups was due
to right to left shunt. However, one may argue that the
pulmonary vascular resistance might have decreased with
the observed improvement in compliance and reduced
CO2 levels, thus resulting in better pulmonary blood ﬂow
and oxygenation. Further investigations are needed to
address the effects of variable ventilation in physiological
and pathological conditions.
The gradient between end-tidal partial pressure of CO2
(PETCO2) and arterial partial pressure of CO2 (PaCO2)
(PET-aCO2) in mechanically ventilated patients presents
a wide range of variation [95]. The reduction of the PET-
aCO2 gradient can be achieved in spontaneously breath-
ing healthy humans using an end-inspiratory rebreathing
technique, which equilibrates end-tidal, alveolar, arterial
and venous PCO2. Based on the aforementioned, Fierstra
et al. [96] investigated whether this method would reduce
the PET-aCO2 gradient in a ventilated animal model. This
technique led to a reduction in the PET-aCO2 gradient,
while the precision of PETCO2 as a surrogate for PaCO2
was independent of the PaCO2, PaO2, and SaO2 as well as
the extent of lung disease. Therefore, the end-inspiratory
rebreathing technique may allow precise, noninvasive
monitoring of PaCO2 in ventilated patients, but further
studies are required to identify the limitations of the
method.
Monitoring of airway systems
Bohr’s dead space (VDBohr) measurement is commonly
calculated using end-tidal CO2 instead of the true alveolar
partial pressure of CO2 (PACO2). Tusman et al. [97]
compared the measurement of VDBohr using PACO2
derived from either volumetric capnography or the stan-
dard alveolar air formula. The authors concluded that
VDBohr can be calculated with accuracy using volumetric
capnography. In a correspondence letter, Graf [98]
expressed concerns about using Bohr’s formula for mea-
suring physiological dead space. The measurement may
refer to airway (VDaw) but not alveolar (VDalv) fraction.
The letter also argued that using CO2 as a tracer of overall
ventilatory efﬁciency still requires the measurement of
VCO2, expired minute ventilation and PaCO2. The value
of PaCO2 may be increased by shunt and/or V/Q
inequalities, leading to physiological dead space overes-
timation. This is an interesting topic, and more studies
and discussion are encouraged to clarify this issue.
Despite all of the technical advances of recent years,
auscultation provides both useful physiological
information and close patient–physician interaction.
Today, there are automated systems that are available to
detect, analyse, and interpret lung sounds. Image-based
techniques of lung sound analysis such as vibration
response imaging have been introduced and tested clini-
cally. However, studies are warranted to determine their
potential role in clinical practice. Vena et al. [99] report
an analysis of the spectral characteristics of lung sounds.
They observed signiﬁcant correlation between intratidal
recruitment measured with dynamic CT and the degree of
crackles in the sound analysis, suggesting that air passage
through atelectasis as well as poorly aerated areas is
crucial for generating lung crackle sounds. They con-
cluded that the computer-based analysis of crackle sounds
is more sensitive for differentiating between small dif-
ferences in healthy and injured conditions, especially at
higher positive end-expiratory pressure (PEEP) levels,
compared to conventional clinical auscultation. This
simple and noninvasive technique of computer-based lung
sound analysis may help intensivists monitor mechanical
ventilation and diagnostic or therapeutic procedures such
as recruitment manoeuvres in real time at the bedside. Yet
the validation of the technique, and the variation of fre-
quent measurements and interpretation of complex
respiratory signals to optimise ventilator settings or to
detect alveolar recruitment, especially in injured lungs,
remain to be further investigated at the bedside [100].
Endotracheal tubes at high volume and low-pressure cuffs
may fail to protect the lower airway from leakage of
potentially contaminated secretions below the longitudi-
nal folds. Ouanes et al. [101] studied the effects of PEEP
levels, inspiratory effort intensity, peak pressures, tracheal
tube cuff materials and sizes on the leakage of ﬂuids past
the cuff in an in vitro model of tracheal intubation and
mechanical ventilation. The authors observed that leakage
occurred more frequently at lower levels of PEEP, higher
inspiratory efforts were associated with higher leakage,
and polyurethane cuffs performed better than polyvinyl-
chloride cuffs. In theory, most aspiration during
mechanical ventilation occurs when tracheal pressure falls
below hydrostatic pressure. Thus, the most important
dependent variables are PEEP, inspiratory efforts and
duty cycles. More studies are required to examine the
effects of mechanical ventilation on leakage across the
cuff.
Lung and distal organ interactions
It is becoming increasingly apparent that lung and brain
represent an integrated physiological ensemble such that
insults involving one will compromise the other and vice
versa [102]. Severe neurological injury is associated
with concurrent lung injury in clinical settings. Recent
studies have shown that acute lung injury may be
responsible for brain injury and poor neurocognitive
201outcomes. However, the underlying biological mecha-
nisms are yet to be elucidated. Heuer et al. [103]
evaluated the independent and combined effects of sus-
tained acute intracranial hypertension (AICH) and
ARDS on lung injury and brain damage in a porcine
model. They observed that markers of lung injury were
augmented with AICH and rose further with concurrent
AICH/ARDS. These observations shed valuable light
on the complex process of signaling, involving neu-
ral, inﬂammatory, immunological, and neuroendocrine
pathways. The fundamental physiological mechanisms
still need to be addressed in future studies investigating
whether the brain injury was due to increased capillary
permeability, and whether the brain edema was vaso-
genic or cytotoxic. Given the signiﬁcant epidemiologic
and mechanistic overlap between sepsis and ALI/ARDS,
it seems plausible that some of the known effects of
sepsis on the brain may be relevant to brain dysfunction
e n c o u n t e r e di nA L I / A R D S[ 102].
The brain is one of the ﬁrst organs affected during
sepsis development; however, the mechanisms associated
with septic encephalopathy are not well known [104].
Comim et al. hypothesised that during sepsis, brain
cytokines and chemokines may lead to alterations in the
blood–brain barrier (BBB) permeability, resulting in an
increase in the ﬂux of inﬂammatory cells and toxic
mediators into the brain, thus contributing to injury. They
demonstrated that the brain’s production of cytokines and
chemokines was an early event during sepsis, and seemed
to participate in both central nervous system dysfunction
and BBB permeability alterations [105].
Studies are needed to demonstrate these links to
enable the development of speciﬁc therapeutic strategies.
Since there is increasing interest in the use of both
pulse pressure variation (PPV) and stroke volume varia-
tion (SVV) to predict preload responsiveness and drive
resuscitation protocols, Mesguida et al. [106] evaluated
the impact of increasing tidal volume, decreased chest
wall compliance, and left ventricular contractility during
intermittent positive-pressure ventilation (IPPV) on the
relation between PPV and left ventricular stroke volume
variation and intrathoracic blood volume changes in dogs.
This study provides a systematic examination of the
changes in the right and left heart pressure and stroke
volumes during the ventilator cycle. The author’s major
conclusion is that there is tight coupling between pulse
pressure and left ventricular SVV. The authors have also
added some important new information that shows the
effect of changes in chest wall compliance, tidal volume
and left ventricular function on the measurements. It is
noteworthy that a proper quantitative analysis would
require integrating the area under the stroke volume
curves of all the stroke volumes in inspiration and expi-
ration. What the author is really showing is that there are
transient differences between the right and left side peak
stroke volumes that must be associated with gains or
losses of pulmonary vascular volume to fulﬁl the con-
servation of mass.
Biomarkers, treatment of hypoxia and sepsis
Reliable biomarkers of sepsis are needed for early diag-
nosis and guidance of appropriate treatment.
Pentraxin 3 (PTX3) is expressed in a variety of cells,
including inﬂammatory (e.g. macrophages, neutrophils,
dendritic cells), endothelial, and epithelial cells. Addi-
tionally, the PTX3 level is well correlated with the
severity of lung injury and multiple organ failure, and
may serve as a biomarker for ALI/ARDS [107]. In order
to analyse the role of PTX3 in an LPS-induced ALI
model, PTX3 knock-out (PTX3-KO) mice were used, and
more severe lung tissue injuries, neutrophil inﬁltration,
cell death, activation of the coagulation cascade, and
inﬂammatory responses were observed, indicating that
PTX3 plays a protective role in the pathogenesis of ALI
[108].
Izquierdo-Garcia et al. [109] conducted a study in
rats where lung tissue, lung lavage ﬂuids and serum
samples were proﬁled from caecal ligation and puncture-
induced sepsis and control groups using NMR and high-
resolution magic angle spinning detection. Predictive
PLS-DA models were constructed based on the NMR
spectra of the three types of biological samples and
employed to diagnose sepsis in other samples. The
authors further reported that the predictive power
obtained by combining the three types of samples was
100%. An advantage of employing metabolomics for
potential diagnosis is the utilisation of bioﬂuids and/or
easily accessible tissues. Because lung tissue collection
is invasive, while sepsis often appears in critically ill
patients, the use of lung tissue for metabolomic analysis
is not practical at the bedside. Moreover, bacteria play a
key role in sepsis, particularly in conditions like peri-
tonitis-associated sepsis. However, bacterium-related
information was absent from their study. Therefore, the
diagnostic value of the clinical treatment provided by
this study is limited. Future studies may need to include
urine samples for metabolomic analysis in order to
understand bacterium-speciﬁc metabolites.
Several mechanisms have been proposed to explain
vascular dysfunction induced by sepsis [110]. Experi-
mental studies have shown that selective and nonselective
inhibitors of vascular potassium (K
?) channels increase
arterial pressure or reverse shock-induced vascular
hyporeactivity [111]. However, while the use of channel
inhibitors remains an attractive option to counteract sys-
temic vasodilation, it may also impair microcirculatory
adaptation to shock [112]. Collin et al. [113] demon-
strated that vascular K
? channels are activated and
overexpressed, while their inhibition restores arterial
pressure and vascular reactivity, and decreases lactate
202concentration, thus offering potential therapeutic per-
spectives for septic shock.
In the search for treatments for critical illnesses, lev-
osimendan has been found to be interesting candidate, as
it is a potent stimulator of vascular ATP-dependent
potassium channels (K
?-ATP channels), inducing sys-
temic vasodilation and reducing afterload. Schwarte et al.
[114] examined the effect of levosimendan on cardiac
output and tissue perfusion in the presence of hypoxia in a
canine model. They found that when levosimendan was
infused before hypoxia was induced, myocardial con-
tractility, stroke volume and cardiac output were
preserved in spite of the hypoxic insult. The novelty of
this study is the examination of the antagonising effect of
glibenclamide on the action of levosimendan. When given
alone, glibenclamide caused a rise in systemic vascular
resistance, suggesting that glibenclamide was acting to
block K
?-ATP channels. When levosimendan was
administered in the presence of glibenclamide, levosim-
endan caused a signiﬁcant rise in cardiac output by
improving myocardial contractility. This is indicative of
levosimendan acting through a calcium-sensitising effect
rather than on K
?-ATP channels. In a separate study,
Revermann et al. [115] reported that the administration of
levosimendan and nicorandil (a K
?-channel opener)
attenuated the increased pulmonary vascular medial wall
thickness in a model of pulmonary hypertension induced
by monocrotaline challenge. Levosimendan signiﬁcantly
diminished the proliferation of pulmonary arterial smooth
muscle cells, and this effect was attenuated by gliben-
clamide. In cell culture, levosimendan had a direct
inhibitory effect on the platelet-derived growth factor
induced proliferation of pulmonary arterial smooth mus-
cle cells. These ﬁndings of levosimendan exerting
inotropic, vasodilatory and anti-inﬂammatory properties
under experimental conditions are exciting, but the real
promise for levosimendan as a therapeutic candidate to
support critical illness remains to be elucidated. Further in
vitro and animal studies are required to understand the
vasodilatory action of levosimendan, and the consequent
effects—positive or negative—on end-organ perfusion
[116]. Acute kidney injury is a common complication in
patients with sepsis.
The primary resuscitation strategy for these patients is
ﬂuid resuscitation to improve organ perfusion and oxy-
genation and thereby prevent distal organ failure. Legrand
et al. [117] examined the effects of ﬂuid resuscitation on
renal perfusion in relation to renal microcirculatory
function in endotoxemic rats. The authors observed that
infusion of endotoxin resulted in altered microvascular
perfusion and oxygenation distributions. Early ﬂuid
resuscitation greatly improved renal perfusion compared
to late resuscitation, but it did not inﬂuence oxygenation
distribution. Serum cytokine levels decreased in the
resuscitated groups, no matter whether early or late
resuscitation was involved. Although the results are
interesting, one has to keep in mind that the study was
conducted at 300 min after endotoxin administration, and
it is unknown whether this time frame is long enough to
fully assess the therapeutic value of immediate versus
delayed resuscitation in clinical situations. There are
several issues that need to be addressed in future studies.
For example, the volume and rate of ﬂuid administration
could simply have altered the disposition of endotoxin in
the kidney. It is unclear how dramatic differences in aortic
and renal artery ﬂow and microvascular ﬂow between
endotoxin alone and endotoxin with ﬂuid resuscitation
had no impact on microvascular oxygen tension. Since the
human erythropoietin fusion protein (EPO) gene was
cloned over 25 years ago, several variants of the EPO
molecule have been developed to improve its pharmaco-
kinetic and pharmacodynamic characteristics and to
separate its haemopoietic and neuroprotective properties
[118]. For example, carbamylated erythropoietin fusion
protein (cEPO-FC) contains two recombinant human EPO
(rhEPO) molecules connected by the Fc region of human
IgG1, and is thought to improve the cytoprotective effects
while reducing side effects including hypertension and
thrombosis. Simon et al. [119] report that pretreatment
with a cEPO-FC is as effective as rhEPO in ameliorating
spinal cord injury in a porcine model of acute spinal cord
ischaemia and reperfusion. This study assessed short-term
outcomes, including motor-evoked potentials and histo-
logical damage. Future studies will need to focus on the
longer-term neurological outcomes and demonstrate an
absence of systemic toxicity, including thrombosis. It is
noteworthy that clinical studies raised the possibility that
rhEPO could improve some clinical outcomes, including
neuronal recovery, but rhEPO failed to show any clinical
beneﬁt with respect to the Barthel index, modiﬁed Rankin
scale and mortality rate in patients with stroke [120, 121].
Thus, further experimental and clinical research is needed
to determine if derivatives of rhEPO such as cEPO-FC
can improve long-term neurological outcome without
having potential adverse effects such as hypertension,
thrombosis and mortality. Reactive oxygen species are
produced by activated neutrophils during the inﬂamma-
tory response to stimuli such as endotoxins, can directly
or indirectly injure host cells, and have been implicated in
the pathogenesis of ALI/ARDS. Hassett et al. [122]
described the result of pulmonary overexpression of
superoxide dismutase in the response to endotoxin
administration in animals. Endotoxin produced a severe
lung injury compared to a sham injury. Their results
support the conclusion that superoxide dismutase plays an
important role in lung injury in terms of neutrophil
inﬁltration, cytokine responses, lung edema and histology.
However, the delivery technique for the superoxide
203dismutase transgene—using adeno-associated virus—
remains controversial. The conclusion that gene therapy
may be appropriate for ALI is a bit premature and need
further studies.
Sepsis affects both oxygen delivery to tissues, through
cardiac and macro- and microcirculatory alterations
[123], and oxygen consumption, through effects on
mitochondrial respiration [124]. Dyson et al. reported that
the early fall in tissue oxygenation was associated with
both macro- and microcirculatory impairment, the latter
persisting despite restoration of the macrocirculation.
However, by 24 h, this impairment had largely recovered,
even though the animal predicted to have a poor prog-
nosis were then manifesting clinical and biochemical
signs of organ dysfunction, suggesting that cellular
abnormalities were enhanced at this later stage [125].
Therefore, the utility of tissue PO2 monitoring to high-
light the local oxygen supply–demand balance, and
dynamic O2 challenge testing to assess microcirculatory
function, merits further investigation.
The beneﬁts of stress-dose steroid therapy and
recombinant activated protein C (APC) in septic shock
remain controversial [126]. Bouazza et al. [127] hypoth-
esised that the combination of APC and steroids would be
beneﬁcial compared with their individual use in resusci-
tated septic shock induced by caecal ligation and
puncture. They observed that either APC or dexametha-
sone improved arterial contractility and endothelial
dysfunction resulting from septic shock; however, their
combination increased survival, thus recommending the
re-evaluation of the combined use of APC and steroids.
The conclusion of the PROWESS-SHOCK study
(still unpublished) that led to the retraction of the APC
from the market has eliminated this molecule from clin-
ical use.
Sepsis is associated with massive discharges of cate-
cholamine and consequent persistent stimulation of the b-
adrenergic receptor [128]. Selective b1-adrenergic
blockers might present a new therapeutic capability
against sepsis [129], although the exact mechanism
remains to be elucidated. Mori et al. [130] observed that
esmolol, a selective b1-blocker, improved outcome in a
rat model of sepsis by preventing gut barrier dysfunction
and thereby bacterial translocation.
Modulating the adrenergic system may be a new
approach to the treatment of sepsis [131]. In rats with
peritonitis, b1-blockade decreased proinﬂammatory
cytokines and improved cardiac function and haemo-
dynamics [129]. However, so far, no study has
evaluated the haemodynamic tolerance of esmolol—a
selective ultrashort-acting b1-blocker—in large animals
with endotoxemic shock. Therefore, Aboab et al. [132]
observed that selective b1-blockade was well tolerated
in endotoxemic pigs treated with a continuous infusion
of esmolol, and prevented sepsis-induced cardiac
dysfunction, conﬁrming ﬁndings reported in small
animals.
Oxidative stress has an important role in the devel-
opment of the systemic inﬂammatory response [133].
Honokiol, a low molecular weight natural product, is an
effective antioxidant and also presents anti-inﬂamma-
tory and antitumor properties [134]. However, the
precise mechanism of action of honokiol on septic acute
lung injury remains unclear. Weng et al. [135] observed
that honokiol administered after the onset of sepsis
reduced acute lung injury and prolonged survival via
the amelioration of oxidative stress in endotoxemic
mice.
Tumor necrosis factor (TNF)-a has been implicated in
the pathogenesis of septic shock. TNF inhibitors resulted
in increased survival in experimental sepsis [136]; how-
ever, no anti-TNF agent modiﬁed survival in clinical
sepsis trials [137]. Fluid therapy may itself have anti-
inﬂammatory effects [138], but is rarely employed in
preclinical sepsis models. Therefore, Qiu et al. [139]
analysed whether the combination of TNFsr and ﬂuids
would be beneﬁcial. They reported that the individual
survival beneﬁts of TNFsr and ﬂuids were not additive in
a rat sepsis model.
Multiple organ dysfunction syndrome (MODS) is
deﬁned as the progressive deterioration of function that
occurs in several organs or systems in patients with septic
shock. Zymosan-induced generalised inﬂammation
reproduces the characteristics of human MODS, and has
been used to evaluate new therapies [140]. Rinaldi et al.
investigated the effects of hyperbaric oxygen (HBO)
exposure on the expression of Toll-like receptors (TLR) 2
and 4, on their signal transduction, and on organ dys-
function during zymosan-induced MODS. They reported
that the anti-inﬂammatory effect of HBO is associated
with the inhibition of TLR signaling, and suggest that
HBO therapy is effective at reducing systemic inﬂam-
mation and associated organ dysfunction in this model
[141].
Reactive oxygen species (ROS) are believed to be
involved in electrical shock (ES) related myocardial
injury [142], ischaemia/reperfusion injury, reperfusion
arrhythmia, and cardiogenic shock. Ascorbic acid, a
potent water-soluble antioxidant, has been found to
attenuate oxidative damage, myocardial injury, and
arrhythmia during reperfusion [143]. However, so far, no
in vivo study has evaluated whether ascorbic acid
administration beneﬁts deﬁbrillation and resuscitation.
Therefore, Tsai et al. [144], in a rat model of ventricular
ﬁbrillation and electrical shock, observed that the
intravenous administration of ascorbic acid at the start of
cardiopulmonary resuscitation reduced lipid peroxida-
tion and myocardial necrosis, diminished mitochon-
drial damage, facilitated resuscitation, and improved
outcome.
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